This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1982 Jun;9(2):85-124.

doi: 10.1016/s0305-7372(82)80012-1.

Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs

G Powis

PMID: 6181872
DOI: 10.1016/s0305-7372(82)80012-1

Review

Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs

G Powis. Cancer Treat Rev. 1982 Jun.

. 1982 Jun;9(2):85-124.

doi: 10.1016/s0305-7372(82)80012-1.

Author

G Powis

PMID: 6181872
DOI: 10.1016/s0305-7372(82)80012-1

No abstract available

PubMed Disclaimer

Similar articles

Clinical pharmacokinetics of commonly used anticancer drugs.
Balis FM, Holcenberg JS, Bleyer WA. Balis FM, et al. Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
[Pharmacokinetics of antitumor drugs].
Filov VA, Kulik GI. Filov VA, et al. Vopr Onkol. 1983;29(7):3-13. Vopr Onkol. 1983. PMID: 6410584 Review. Russian. No abstract available.
Sparfosate. A novel biomodulator of 5-fluorouracil.
Koshland P, Maa L, Ignoffo R. Koshland P, et al. Cancer Pract. 1999 Jul-Aug;7(4):212-6. doi: 10.1046/j.1523-5394.1999.74011.x. Cancer Pract. 1999. PMID: 10687588 Review. No abstract available.
[Pharmacokinetics of antineoplastic agents (author's transl)].
Carcassonne Y, Cano JP, Meyer G. Carcassonne Y, et al. Bull Cancer. 1979;66(1):39-42. Bull Cancer. 1979. PMID: 311229 French.
Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in man.
Lankelma J, Penders PG, Leyva A, Kleeberg UR, Kenny JB, Bramwell V, McVie JG, Pinedo HM. Lankelma J, et al. Eur J Cancer Clin Oncol. 1981 Nov;17(11):1199-204. Eur J Cancer Clin Oncol. 1981. PMID: 7199467 No abstract available.

See all similar articles

Cited by

Can pharmacokinetic monitoring improve clinical use of fluorouracil?
Young AM, Daryanani S, Kerr DJ. Young AM, et al. Clin Pharmacokinet. 1999 Jun;36(6):391-8. doi: 10.2165/00003088-199936060-00001. Clin Pharmacokinet. 1999. PMID: 10427464 Review.
Pharmacokinetically guided administration of chemotherapeutic agents.
van den Bongard HJ, Mathôt RA, Beijnen JH, Schellens JH. van den Bongard HJ, et al. Clin Pharmacokinet. 2000 Nov;39(5):345-67. doi: 10.2165/00003088-200039050-00004. Clin Pharmacokinet. 2000. PMID: 11108434 Review.
Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.
Moore MJ, Erlichman C. Moore MJ, et al. Clin Pharmacokinet. 1987 Oct;13(4):205-27. doi: 10.2165/00003088-198713040-00001. Clin Pharmacokinet. 1987. PMID: 3311530 Review.
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy.
Karimian A, Ji NT, Song H, Sgouros G. Karimian A, et al. Cancer Res. 2020 Feb 15;80(4):868-876. doi: 10.1158/0008-5472.CAN-19-2553. Epub 2019 Nov 26. Cancer Res. 2020. PMID: 31772036 Free PMC article.
Problems in the use of anticancer drugs in the elderly.
Phister JE, Jue SG, Cusack BJ. Phister JE, et al. Drugs. 1989 Apr;37(4):551-65. doi: 10.2165/00003495-198937040-00007. Drugs. 1989. PMID: 2661198 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information